These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 6955735)

  • 41. [Reversible pituitary-adrenal insufficiency produced by busulfan].
    García-San Miguel J; Pujol-Moix N
    Rev Clin Esp; 1968 Sep; 110(5):467-72. PubMed ID: 4247382
    [No Abstract]   [Full Text] [Related]  

  • 42. [Pulmonary alveolar fibrosis caused by Myleran (busulfan)].
    Etcheberry R; Becker P; Delmastro J; Donoso S
    Rev Med Chil; 1973 Jan; 101(1):42-6. PubMed ID: 4518637
    [No Abstract]   [Full Text] [Related]  

  • 43. Busulfan in early pregnancy.
    Williams DW
    Obstet Gynecol; 1966 May; 27(5):738-40. PubMed ID: 5220059
    [No Abstract]   [Full Text] [Related]  

  • 44. Combination chemotherapy for chronic granulocytic leukaemia.
    Allan NC; Duvall E; Stockdill G
    Lancet; 1978 Sep; 2(8088):523. PubMed ID: 79887
    [No Abstract]   [Full Text] [Related]  

  • 45. [Terminal phase of chronic granulocytic leukemia].
    Pawlowski J
    Pol Tyg Lek; 1969 Jan; 24(1):14-7. PubMed ID: 5255159
    [No Abstract]   [Full Text] [Related]  

  • 46. [Results of treatment and survival time in chronic granulocytic leukemia].
    Pawlowski J
    Przegl Lek; 1969; 25(3):305-9. PubMed ID: 4182966
    [No Abstract]   [Full Text] [Related]  

  • 47. Survival in chronic granulocytic leukemia. Splenic irradiation vs busulfan.
    Conrad FG
    Arch Intern Med; 1973 May; 131(5):684-5. PubMed ID: 4512787
    [No Abstract]   [Full Text] [Related]  

  • 48. [Aplastic syndrome in myleran overdose].
    Albrecht M; Tackmann W; Pribilla W
    Med Klin; 1971 Jan; 66(4):126-30. PubMed ID: 5278287
    [No Abstract]   [Full Text] [Related]  

  • 49. [Treatment of chronic myeloid leukemia with dibromomannitol].
    Clément F; Saillen R
    Schweiz Med Wochenschr; 1970 Nov; 100(46):1995-7. PubMed ID: 5279364
    [No Abstract]   [Full Text] [Related]  

  • 50. Cholestatic jaundice following treatment of chronic granulocytic leukemia with busulphan.
    Underwood JC; Shahani RT; Blackburn EK
    J Clin Pathol; 1970 Dec; 23(9):827. PubMed ID: 5278972
    [No Abstract]   [Full Text] [Related]  

  • 51. [A CASE OF LEUKEMIA IN A LACTATING FEMALE: EFFECT OF TREATMENT WITH BUSULFAN ON THE INFANT].
    BOUNAMEAUX Y; DURENNE JM
    Ann Soc Belges Med Trop Parasitol Mycol; 1964; 44():381-3. PubMed ID: 14259241
    [No Abstract]   [Full Text] [Related]  

  • 52. Busulfan-induced hemorrhagic cystitis.
    Pode D; Perlberg S; Steiner D
    J Urol; 1983 Aug; 130(2):347-8. PubMed ID: 6576177
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Long-term survival in chronic granulocytic leukemia].
    Coliţă A; Butoianu E; Nicoară S; Gociu M; Munteanu N; Hossu T; Ciocoiu A; Berceanu S
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1983; 35(3):247-52. PubMed ID: 6140719
    [No Abstract]   [Full Text] [Related]  

  • 54. Busulfan lung: cytologic diagnosis.
    Dalri P; Piscioli F; Detassis C
    Haematologica; 1980 Aug; 65(4):469-74. PubMed ID: 6774919
    [No Abstract]   [Full Text] [Related]  

  • 55. Jaundice after treatment of leukemia with busulphan.
    Underwood JC; Shahani RT; Blackburn EK
    Br Med J; 1971 Mar; 1(5748):556-7. PubMed ID: 5280623
    [No Abstract]   [Full Text] [Related]  

  • 56. [Preliminary results of myelobromol treatment of chronic granulocytic leukemia].
    Urasiński I; Mysik M
    Wiad Lek; 1971 Jul; 24(3):271-4. PubMed ID: 5279032
    [No Abstract]   [Full Text] [Related]  

  • 57. [Kinetic constants of leukocyte reduction in the course of treatment of chronic myeloleukosis with different doses of myelosan].
    Levitin EI; Kukharenko IuA; Evsenko LS; Emanuel' NM
    Izv Akad Nauk SSSR Biol; 1968; 5():739-43. PubMed ID: 5262634
    [No Abstract]   [Full Text] [Related]  

  • 58. [Busulfan and eye complications].
    Tuppurainen K; Nousiainen T; Lahtinen R
    Duodecim; 1985; 101(24):2420-2. PubMed ID: 3866686
    [No Abstract]   [Full Text] [Related]  

  • 59. Delayed toxic effect of busulfan on the marrow.
    Ganda OP; Mangalik A
    J Assoc Physicians India; 1973 Jun; 21(6):511-6. PubMed ID: 4525264
    [No Abstract]   [Full Text] [Related]  

  • 60. Treatment of chronic granulocytic leukemia.
    Can Med Assoc J; 1968 Jul; 99(3):129-30. PubMed ID: 4877613
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.